News
Eli Lilly’s obesity drug Zepbound led to nearly 50 percent more weight loss than Novo Nordisk’s Wegovy in the first direct ...
The Knesset Health Committee discussed worrying obesity statistics in Israel: one in five children and adolescents suffer ...
From canola oil to colorful dyes, the US food industry is girding for a shift away from the ingredients that made American ...
For everything that was wrong about WeightWatchers, once upon a time it did something right. It tapped into the power of ...
The prevalence of obesity among young people in the UK represents a significant challenge within the field of public health.
A digital obesity clinic, Embla, is associated with 16.7% weight loss over 64 weeks, matching previous semaglutide trial ...
Explore more
A new study shows that people who develop type 1 diabetes in adulthood have an increased risk of cardiovascular disease and death, and that those diagnosed later in life do not have a better prognosis ...
Novo Nordisk's current product portfolio is well-protected by patents until at least 2030. Click here to see why NVO stock is ...
A new nationwide analysis is shedding light on how states compare when it comes to a major public health challenge, and the ...
Today, we're putting a super popular workout under the microscope: CrossFit. And we're tackling a big question: Is it the ...
Forge says it will provide Fractyl process development, cGMP manufacturing, and analytical development services.
Doctors generally have an easier time diagnosing type 1 diabetes in kids, who present with classic symptoms of excessive thirst, excessive urination, and weight loss. “Children often have a really ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results